Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frydenberg

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Plos One|November 13, 2023
Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in AustraliaJessica K Cameron, Upeksha Chandrasiri, Jeremy Millar, et al.
BJU International|January 8, 2026
Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
Australian Health Review : a Publication of the Australian Hospital Association|February 11, 2024
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosisDaniel Lindsay, Penelope Schofield, Doreen Nabukalu, et al.
Trials|January 12, 2021
Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partnersPenelope Schofield, Karla Gough, Amelia Hyatt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 18, 2016
The role of mindfulness in distress and quality of life for men with advanced prostate cancerSuzanne K Chambers, Elizabeth Foley, Samantha Clutton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled TrialSuzanne K Chambers, Stefano Occhipinti, Elizabeth Foley, et al.
Palliative & Supportive Care|October 10, 2019
A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patientsJoanne Brooker, John Julian, Jeremy Millar, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Scientific Reports|March 19, 2021
Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostateSophie N Lee, Jenna Kraska, Melissa Papargiris, et al.
European Urology|November 3, 2018
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 ConsortiumMieke Van Hemelrijck, Xi Ji, Jozien Helleman, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Plos One|November 13, 2023
Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in AustraliaJessica K Cameron, Upeksha Chandrasiri, Jeremy Millar, et al.
BJU International|January 8, 2026
Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
Australian Health Review : a Publication of the Australian Hospital Association|February 11, 2024
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosisDaniel Lindsay, Penelope Schofield, Doreen Nabukalu, et al.
Trials|January 12, 2021
Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partnersPenelope Schofield, Karla Gough, Amelia Hyatt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 18, 2016
The role of mindfulness in distress and quality of life for men with advanced prostate cancerSuzanne K Chambers, Elizabeth Foley, Samantha Clutton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled TrialSuzanne K Chambers, Stefano Occhipinti, Elizabeth Foley, et al.
Palliative & Supportive Care|October 10, 2019
A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patientsJoanne Brooker, John Julian, Jeremy Millar, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Scientific Reports|March 19, 2021
Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostateSophie N Lee, Jenna Kraska, Melissa Papargiris, et al.
European Urology|November 3, 2018
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 ConsortiumMieke Van Hemelrijck, Xi Ji, Jozien Helleman, et al.
Pageof 19